Sponsor Pipeline

Rahul Aggarwal Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
2
Recruiting
6
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-24 NCT06942104
Imaging of Solid Tumors Using 18F-TRX		 date change Primary completion pushed: 2026-09-30 -> 2027-09-30
2026-07-24 NCT06942104
Imaging of Solid Tumors Using 18F-TRX		 date change Completion pushed: 2026-09-30 -> 2027-09-30
Active Trials by Phase
Phase 2
2
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT03682289 Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients… Clear Cell Renal Cell Carcinoma Active, Not Recruiting
NCT04471974 ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic… Castration-Resistant Prostate Carcinoma Active, Not Recruiting
Phase 1/2
NCT05888532 64Cu-GRIP B in Patients With Advanced Malignancies Prostate Cancer Recruiting
NCT05011188 FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant… Metastatic Castration-resistant Prostate Cancer Active, Not Recruiting
Phase 1
NCT06942104 Imaging of Solid Tumors Using 18F-TRX Solid Tumor Recruiting
Disease Areas
Prostate Cancer (5) Kidney Cancer (3) Pancreatic Cancer (1) Bladder Cancer (1) Endometrial Cancer (1) Glioma (1)
Get alerts when Rahul Aggarwal's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free